Deltanoid Finishes Series B

Deltanoid Pharmaceuticals, a Madison, Wis.-based pharmaceutical development company, has announced completion of its $12 million Series B financing, bringing total funding to date to more than $16 million. All funds were raised from previous investors in Deltanoid, led by the Wisconsin Alumni Research Foundation, an independent, non-profit technology transfer organization that supports research at the University of Wisconsin-Madison, as well as two local venture capital firms, Mason Wells and Venture Investors. Other investors included a local corporation, company founders and angel investors www.deltanoid.com